PTAFR
Platelet-activating factor receptor
Also known as: PTAFR_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P25105
- Gene
- PTAFR
- Ensembl
- ENSG00000169403
- Chromosome
- 1
- Canonical length
- 342 aa
- Protein class
- FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters
- Subcellular location
- Nucleoplasm,Vesicles,Plasma membrane,Primary cilium
OverviewNCBI Gene
This gene encodes a seven-transmembrane G-protein-coupled receptor for platelet-activating factor (PAF) that localizes to lipid rafts and/or caveolae in the cell membrane. PAF (1-0-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine) is a phospholipid that plays a significant role in oncogenic transformation, tumor growth, angiogenesis, metastasis, and pro-inflammatory processes. Binding of PAF to the PAF-receptor (PAFR) stimulates numerous signal transduction pathways including phospholipase C, D, A2, mitogen-activated protein kinases (MAPKs), and the phosphatidylinositol-calcium second messenger system. Following PAFR activation, cells become rapidly desensitized and this refractory state is dependent on PAFR phosphorylation, internalization, and down-regulation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]
Canonical amino-acid sequenceUniProt
342 residues, UniProt reviewed canonical sequence.
>P25105|PTAFR
1 MEPHDSSHMD SEFRYTLFPI VYSIIFVLGV IANGYVLWVF ARLYPCKKFN EIKIFMVNLT
61 MADMLFLITL PLWIVYYQNQ GNWILPKFLC NVAGCLFFIN TYCSVAFLGV ITYNRFQAVT
121 RPIKTAQANT RKRGISLSLV IWVAIVGAAS YFLILDSTNT VPDSAGSGNV TRCFEHYEKG
181 SVPVLIIHIF IVFSFFLVFL IILFCNLVII RTLLMQPVQQ QRNAEVKRRA LWMVCTVLAV
241 FIICFVPHHV VQLPWTLAEL GFQDSKFHQA INDAHQVTLC LLSTNCVLDP VIYCFLTKKF
301 RKHLTEKFYS MRSSRKCSRA TTDTVTEVVV PFNQIPGNSL KNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PTAFR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 39 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 39 nTPM
- appendix: 29 nTPM
- tonsil: 17 nTPM
- lung: 17 nTPM
- spleen: 14 nTPM
- urinary bladder: 13 nTPM
Single-cell type
- neutrophils: 466 nCPM
- kupffer cells: 147 nCPM
- monocytes: 145 nCPM
- neutrophil progenitors: 117 nCPM
- microglia: 115 nCPM
- hofbauer cells: 114 nCPM
Immune cell
- eosinophil: 909 nTPM
- neutrophil: 750 nTPM
- classical monocyte: 257 nTPM
- myeloid DC: 116 nTPM
- total PBMC: 112 nTPM
- intermediate monocyte: 78 nTPM
Brain region
- white matter: 23 nTPM
- medulla oblongata: 17 nTPM
- spinal cord: 16 nTPM
- pons: 14 nTPM
- thalamus: 14 nTPM
- midbrain: 13 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.85
- gnomAD pLI
- 0.24
- gnomAD missense Z
- 1.45
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chemotaxis
- G protein-coupled receptor signaling pathway
- immune response
- inflammatory response
- inositol trisphosphate biosynthetic process
- phospholipase C-activating G protein-coupled receptor signaling pathway
Molecular functions
- G protein-coupled purinergic nucleotide receptor activity
- G protein-coupled receptor activity
- lipopolysaccharide binding
- lipopolysaccharide immune receptor activity
- phospholipid binding
- platelet activating factor receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- G protein-coupled receptor, rhodopsin-like
- GPCR, rhodopsin-like, 7TM
- 7 transmembrane receptor (rhodopsin family)
- Platelet-activating factor receptor
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PTAFR in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PTAFR as an antibody target. Whether an autoantibody or antibody against PTAFR could matter depends on whether native PTAFR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PTAFR is annotated at the cell surface, where native PTAFR is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PTAFR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...